rs4797824
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000327606.4(MC2R):c.*111G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.3 in 1,188,524 control chromosomes in the GnomAD database, including 55,618 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.28 ( 6162 hom., cov: 32)
Exomes 𝑓: 0.30 ( 49456 hom. )
Consequence
MC2R
ENST00000327606.4 3_prime_UTR
ENST00000327606.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.741
Genes affected
MC2R (HGNC:6930): (melanocortin 2 receptor) MC2R encodes one member of the five-member G-protein associated melanocortin receptor family. Melanocortins (melanocyte-stimulating hormones and adrenocorticotropic hormone) are peptides derived from pro-opiomelanocortin (POMC). MC2R is selectively activated by adrenocorticotropic hormone, whereas the other four melanocortin receptors recognize a variety of melanocortin ligands. Mutations in MC2R can result in familial glucocorticoid deficiency. Alternate transcript variants have been found for this gene. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 18-13884514-C-T is Benign according to our data. Variant chr18-13884514-C-T is described in ClinVar as [Benign]. Clinvar id is 326188.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.32 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC2R | NM_000529.2 | c.*111G>A | 3_prime_UTR_variant | 2/2 | ENST00000327606.4 | NP_000520.1 | ||
MC2R | NM_001291911.1 | c.*111G>A | 3_prime_UTR_variant | 2/2 | NP_001278840.1 | |||
MC2R | XM_017025781.2 | c.*111G>A | 3_prime_UTR_variant | 3/3 | XP_016881270.1 | |||
MC2R | XM_047437537.1 | c.*111G>A | 3_prime_UTR_variant | 4/4 | XP_047293493.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC2R | ENST00000327606.4 | c.*111G>A | 3_prime_UTR_variant | 2/2 | 1 | NM_000529.2 | ENSP00000333821 | P1 |
Frequencies
GnomAD3 genomes AF: 0.277 AC: 42049AN: 151916Hom.: 6166 Cov.: 32
GnomAD3 genomes
AF:
AC:
42049
AN:
151916
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.304 AC: 314837AN: 1036490Hom.: 49456 Cov.: 14 AF XY: 0.300 AC XY: 160135AN XY: 533564
GnomAD4 exome
AF:
AC:
314837
AN:
1036490
Hom.:
Cov.:
14
AF XY:
AC XY:
160135
AN XY:
533564
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.277 AC: 42043AN: 152034Hom.: 6162 Cov.: 32 AF XY: 0.277 AC XY: 20574AN XY: 74294
GnomAD4 genome
AF:
AC:
42043
AN:
152034
Hom.:
Cov.:
32
AF XY:
AC XY:
20574
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
593
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Glucocorticoid deficiency 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at